Strategic Research Institute Release: Largest Industry Conference On Inflammatory Diseases To Feature Pharma Updates On Drugs For MS, COPD & Asthma, March 20-21, 2006 New Brunswick, NJ

NEW BRUNSWICK, N.J., Jan. 25 /PRNewswire/ -- The 10th Anniversary Inflammation & Immune Diseases Drug Discovery & Development Summit, considered to be the best-attended & longest running meeting for the pharmaceutical and biotechnology inflammation communities will convene on March 20-21, 2006 in New Brunswick, NJ. The 2006 meeting brings together the world industrial community of over 150 immunology & inflammatory researchers for their annual review on their programs intended to generate next generation drugs, announces Strategic Research Institute.

The agenda offers the latest clinical updates on Tysabri(R) (natalizumab), Daxas(R) (roflumilast), PI3K for RA, LFA-1 Inhibition, H4 Receptors for Allergy, Src-family Lck Inhibitors, TLR Novel Targets for Autoimmunity, and many more. The following highlighted keynotes are listed in detail below:

To B or not to B: Targeting of Activation Induced Cytidine Deaminase as a Novel B Cell Therapy for Autoimmune Disease and Arthritis

John Mountz, M.D., Ph.D. Professor, Department of Medicine Division of Clinical Immunology & Rheumatology UNIVERSITY OF ALABAMA BIRMINGHAM Natalizumab, Clinical Effects of Alpha-4 Integrin Blockade Gordon Francis, M.D. VP, Global Clinical Development ELAN PHARMACEUTICALS Complete and updated list of presenting companies and institutions includes: * 3M Pharmaceuticals * Abbott Laboratories * Altana Pharma US * Altana Pharma AG * Amira Pharmaceuticals * AstraZeneca * AstraZeneca R&D Charnwood, UK * Atherogenics, Inc. * Biogen Idec * Celgene Corporation * Celgene San Diego * Corgentech, Inc. * Cytimmune Sciences, Inc. * Elan Pharmaceuticals * EntreMed, Inc. * Hoffman-La Roche * IsisPharmaceuticals * Isogenis, Inc. * Johnson & Johnson Pharmaceutical R&D * MD Biosciences * MedImmune * Merck Research Laboratories * National Institute of Standards & Technology * Novartis Pharma * Novosom AG * Pliva Research Institute Ltd. * Sangamo Biosciences * Serono Pharmaceutical Research Institute * Ben-Gurion University Medical Center * Texas Tech University Health Sciences Center * University of Alabama Birmingham * University of Copenhagen, Denmark

To register for the event, please visit http://www.srinstitute.com/IIDS. THE LAST DAY TO REGISTER FOR THE DISCOUNTED RATE ($200 OFF) IS JAN. 31.

To receive the full agenda in PDF, please contact Ed Drilon of Strategic Research Institute at edrilon@srinstitute.com or 212-967-0095, x233 (please include name and corporate affiliation.

Leverage our strong position in the industrial inflammatory and immune diseases area to showcase your products and services to this high-level, targeted audience of pharmaceutical scientists and executive decision makers. To inquire about sponsorship & exhibition opportunities, please contact Ed Drilon at 212-967-0095 x233, edrilon@srinstitute.com. LUNCHEON AND RECEPTION SPEAKING OPPORTUNITIES FOR BOTH DAYS REMAIN AVAILABLE.

Strategic Research Institute

CONTACT: Ed Drilon, of Strategic Research Institute, +1-212-967-0095 x233,edrilon@srinstitute.com

MORE ON THIS TOPIC